REgulatory T Cell Therapy to Achieve Immunosuppression REduction

Clinical trial NCT06552169 · RECRUITING

Trial details

NCT number: NCT06552169
Sponsor: Singulera Therapeutics Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Transplantation

Start date: 2025-06-13
Primary completion: 2027-12-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.